Abstract 14366: Not All Factor Xa Inhibitors Are Equal: Apixaban a Better Choice Than Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients: Evidence from a Meta-Analysis
Introduction: Behind every atrial fibrillation diagnosis lies a fivefold increased stroke risk, leading to inclusion of anticoagulant therapy. Transition from Vitamin K antagonists to Direct Oral Anti Coagulants (DOACs) has revolutionized anticoagulation in non-valvular atrial fibrillation, increasing compliance and...